Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-EN Version v11-EN
Language English English
Date Updated 2022-04-01 2022-03-22
Drug Identification Number 00023450 00023450
Brand name DILANTIN-125 SUSPENSION DILANTIN-125 SUSPENSION
Common or Proper name Dilantin Dilantin
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients PHENYTOIN PHENYTOIN
Strength(s) 125MG 125MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size Oral Suspension 250ml Oral Suspension 250ml
ATC code N03AB N03AB
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-12-23 2021-12-23
Actual start date 2022-01-07 2022-01-07
Estimated end date 2022-04-01 2022-03-25
Actual end date 2022-03-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments One lot with an expiry date of June/30/2022 remains available in stock One lot with an expiry date of June/30/2022 remains available in stock
Health Canada comments